MissionIR Articles

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a biopharmaceutical company, is focused on developing novel therapeutics based on RNA interference, or RNAi. By applying its therapeutic expertise in RNAi, the company intends to address substantial medical needs,…

Lorus Therapeutics, Inc. (AMEX: LRP), a biopharmaceutical company, is focused on discovering, researching and developing effective anticancer therapies with high safety profiles. By utilizing its own discovery efforts, in addition to acquisition and in-licensing programs,…

LightPath Technologies, Inc. (NASDAQ: LPTH) is a recognized leader in optical solutions for industrial, defense, communications, test and measurement, and medical applications. With unique products such as Black Diamond Infrared Lenses and Gradium Lenses, LightPath…

Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company, is committed to developing and commercializing innovative small molecule drugs for the treatment of cancer. Pralatrexate (PDX), the Company’s lead product candidate, is a novel antifolate currently…

LCA-Vision, Inc. (NASDAQ: LCAV) provides laser vision correction services under its well known Lasik Plus brand. The company currently owns and operates over 70 LasikPlus fixed-site laser vision correction centers in the United States and…

La Jolla Pharmaceutical Company (NASDAQ: LJPC) is focused on improving and preserving human life through the development of novel pharmaceutical products. Riquent®, the company’s leading product in development, treats lupus renal disease, a leading cause…

AgFeed Industries, Inc. (NASDAQ: FEED), the largest commercial hog producer and the largest premix feed company in China, owns and operates 28 commercial hog farms with annual production of more than 650,000 hogs and five…

Advanced Life Sciences Holdings, Inc. (NASDAQ: ADLS), a biopharmaceutical company, is focused discovering, developing, and commercializing novel drugs in the therapeutic areas of respiratory diseases, infection, and cancer. Cethromycin, the Company’s lead candidate, is a…

Advanced Battery Technologies, Inc. (NASDAQ: ABAT), a developer, manufacturer and distributor of rechargeable Polymer Lithium-Ion (PLI) batteries, is focused on developing batteries that overcome many of the shortcomings of traditional rechargeable batteries by combining high-energy…

Adherex Technologies, Inc. (AMEX: ADH), a biopharmaceutical company, is focused on discovering and developing novel cancer therapeutics. They currently have a number of products in the clinical stage of development, including eniluracil, ADH-1 and sodium…

Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI) is focused on commercializing patent-protected disruptive healthcare technologies specifically designed to take leading roles for the treatment of a broad array of chronic, debilitating and life-threatening diseases including respiratory, autoimmune…

Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI) is focused on commercializing patent-protected disruptive healthcare technologies specifically designed to take leading roles for the treatment of a broad array of chronic, debilitating and life-threatening diseases including respiratory, autoimmune…

ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD), a biopharmaceutical company, is focused on utilizing innovative technology to stimulate drug discovery and clinical development of novel treatments for central nervous system disorders. The company is currently developing a…

Aastrom Biosciences, Inc. (NASDAQ: ASTM) is focused on the development of autologous cell products for the repair or regeneration of human tissue. The Company’s proprietary Tissue Repair Cell (TRC) technology utilizes a patient’s own cells…

A.P. Pharma, Inc. (NASDAQ: APPA), a specialty pharmaceutical company, is committed to developing ethical (prescription) pharmaceuticals through the utilization of its proprietary polymer-based drug delivery systems. The Company’s main focus is on developing and commercializing…

Kona Grill, Inc. (NASD: KONA), an American grill and sushi bar, recently announced its financial results for the third quarter ended September 30, 2008. Restaurant sales from continuing operations increased 4.3 percent to $19.5 million…

Adherex Technologies, Inc. (AMEX: ADH), a biopharmaceutical company, is focused on discovering and developing novel cancer therapeutics. They currently have a number of products in the clinical stage of development, including eniluracil, ADH-1 and sodium…

Business applications company NetSol Technologies Inc. (NASDAQ: NTWK) announced it will purchase Ciena Solutions LLC. Under the terms of the agreement, the acquisition will be made with internal cash and restricted stock, and deferred “based…

Earlier today, Heckmann Corp. announced that it has completed its merger with China Water and Drinks Inc. As terms of the agreement, China Water is now a wholly-owned subsidiary of Heckmann Corp. and its stock…

Safeguard Scientifics, Inc., a holding company that provides capital and business resources to its partner companies in the information technology and life sciences fields, announced a 59% growth in the third quarter revenue. Consolidated revenue…